Doctor Hiromi Matsubara

The participant’s research interests have focused on clinical and physiological aspects of　pulmonary hypertension. He has worked to improve the outcome of treatment for pulmonary　arterial hypertension and started high-dose and rapid up-titration of epoprostenol combined　with other oral drugs. As a result, long term survival of the patients treated at Okayama　Medical Center was remarkably improved. Then, he started balloon pulmonary angioplasty　(BPA) for chronic thromboembolic pulmonary hypertension in 2004. He has experienced　about 2100 procedures of BPA in more than 370 patients during past 14 years. He is going　to establish the safety and efficacy of BPA. He has made Department of Cardiology at　Okayama Medical Center as the largest BPA center in Japan.